Stay updated on Pimavanserin Safety in Neurodegenerative Disease Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page.

Latest updates to the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, with no visible change to the study record.SummaryDifference0.1%

- Check25 days agoChange DetectedA banner announces NIH’s website transition and says federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” under Executive Order 14434. It is separate from the study information.SummaryDifference0.5%

- Check32 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check39 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check60 days agoChange DetectedThe study history now shows a new Revision: v3.7.0 entry, reflecting an updated version of the record. The earlier Revision: v3.6.6 entry has been removed from the visible history.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision entry for the page history (v3.6.6) was added, and the previous revision (v3.6.5) was removed, reflecting a maintenance update to the record's metadata.SummaryDifference0.1%

Stay in the know with updates to Pimavanserin Safety in Neurodegenerative Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page.